Two Sigma Investments’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.8M Sell
1,827,994
-903,293
-33% -$889K ﹤0.01% 1874
2025
Q1
$3.93M Sell
2,731,287
-809,074
-23% -$1.17M 0.01% 1215
2024
Q4
$7.79M Sell
3,540,361
-84,698
-2% -$186K 0.02% 823
2024
Q3
$5.98M Sell
3,625,059
-449,902
-11% -$742K 0.01% 948
2024
Q2
$9.05M Buy
4,074,961
+99,401
+3% +$221K 0.02% 706
2024
Q1
$10.7M Buy
3,975,560
+1,641,150
+70% +$4.4M 0.03% 598
2023
Q4
$6.98M Buy
2,334,410
+876,475
+60% +$2.62M 0.02% 773
2023
Q3
$1.43M Buy
1,457,935
+281,087
+24% +$275K ﹤0.01% 1639
2023
Q2
$1.64M Buy
1,176,848
+113,950
+11% +$158K ﹤0.01% 1529
2023
Q1
$1.69M Sell
1,062,898
-474,766
-31% -$755K ﹤0.01% 1433
2022
Q4
$9.58M Buy
1,537,664
+469,226
+44% +$2.92M 0.03% 549
2022
Q3
$7.16M Buy
1,068,438
+686,035
+179% +$4.6M 0.02% 598
2022
Q2
$2.43M Buy
382,403
+242,504
+173% +$1.54M 0.01% 1053
2022
Q1
$649K Sell
139,899
-202,748
-59% -$941K ﹤0.01% 1854
2021
Q4
$1.71M Buy
+342,647
New +$1.71M ﹤0.01% 1396
2021
Q2
Sell
-48,670
Closed -$1.37M 2538
2021
Q1
$1.37M Sell
48,670
-3,294
-6% -$92.4K ﹤0.01% 1456
2020
Q4
$1.35M Buy
51,964
+33,034
+175% +$859K ﹤0.01% 1233
2020
Q3
$704K Sell
18,930
-9,202
-33% -$342K ﹤0.01% 1292
2020
Q2
$1.44M Buy
+28,132
New +$1.44M 0.01% 1007
2019
Q4
Sell
-39,484
Closed -$1.45M 2255
2019
Q3
$1.45M Sell
39,484
-105,290
-73% -$3.86M ﹤0.01% 1049
2019
Q2
$6.74M Buy
144,774
+120,252
+490% +$5.59M 0.02% 632
2019
Q1
$985K Buy
+24,522
New +$985K ﹤0.01% 1433
2017
Q3
Sell
-69,877
Closed -$3.23M 1996
2017
Q2
$3.23M Sell
69,877
-20,241
-22% -$937K 0.01% 862
2017
Q1
$3.18M Buy
+90,118
New +$3.18M 0.01% 957
2015
Q3
Sell
-273,502
Closed -$22.4M 1755
2015
Q2
$22.4M Buy
273,502
+134,519
+97% +$11M 0.1% 238
2015
Q1
$12.9M Buy
138,983
+100,733
+263% +$9.33M 0.06% 392
2014
Q4
$1.55M Buy
+38,250
New +$1.55M 0.01% 1154